Effects of cancer on platelets

Seminars in Oncology

Volumn 41, Issue 3, 2014, Pages 311-318

  Van Es, Nick ^a   Sturk, Auguste ^a   Middeldorp, Saskia ^a   Nieuwland, Rienk ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOGENIC PROTEIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; GRANULOCYTE COLONY STIMULATING FACTOR; PRASUGREL; THROMBIN; THROMBOPLASTIN; TICAGRELOR;

ARTERY THROMBOSIS; ARTICLE; BLOOD CLOTTING; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER PATIENT; CANCER PREVENTION; CANCER SURVIVAL; CHEMOPROPHYLAXIS; CIRCULATING TUMOR CELL; CIRCULATION; COLON CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL (TOPIC); ERYTHROCYTE; ESOPHAGUS CANCER; EX VIVO STUDY; HUMAN; LUNG CANCER; MEGAKARYOCYTE; MEGAKARYOPOIESIS; METASTASIS; NEOPLASM; NEUTROPHIL; PRIORITY JOURNAL; PROSTATE CANCER; STOMACH CANCER; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; THROMBOCYTOSIS; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

ANIMALS; BLOOD PLATELETS; HUMANS; NEOPLASMS; THROMBOCYTOPENIA;

EID: 84904201548     PISSN: 00937754     EISSN: 15328708     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2014.04.015     Document Type: Article

References (65)

1. L. Riess Zur pathologischen Anatomie des Blutes Arch Anat Physiol Wissensch Med 39 1872 237 249
2. J. Levin, and C.L. Conley Thrombocytosis associated with malignant disease Arch Intern Med 114 1964 497 500
3. A.A. Khorana, C.W. Francis, E. Culakova, and G.H. Lyman Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study Cancer 104 2005 2822 2829
4. G.F. Nash, L.F. Turner, M.F. Scully, and A.K. Kakkar Platelets and cancer Lancet Oncol 3 2002 425 430
5. A. Maráz, J. Furák, Z. Varga, Z. Kahán, L. Tiszlavicz, and K. Hideghéty Thrombocytosis has a negative prognostic value in lung cancer Anticancer Res 33 2013 1725 1729
6. R.L. Stone, A.M. Nick, I.A. McNeish, F. Balkwill, H.D. Han, and J. Bottsford-Miller et al. Paraneoplastic thrombocytosis in ovarian cancer N Engl J Med 366 2012 610 618
7. T.S. Njølstad, H. Engerud, H.M.J. Werner, H.B. Salvesen, and J. Trovik Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas Gynecol Oncol 131 2013 410 415
8. A. Ayhan, G. Bozdag, C. Taskiran, M. Gultekin, K. Yuce, and T. Kucukali The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma Gynecol Oncol 103 2006 902 905
9. K. Kawai, J. Kitayama, N.H. Tsuno, E. Sunami, and T. Watanabe Thrombocytosis before pre-operative chemoradiotherapy predicts poor response and shorter local recurrence-free survival in rectal cancer Int J Colorectal Dis 28 2013 527 535
10. A. Cravioto-Villanueva, P. Luna-Perez, M. Gutierrez-de la Barrera, H. Martinez-Gómez, A. Maffuz, and P. Rojas-Garcia et al. Thrombocytosis as a predictor of distant recurrence in patients with rectal cancer Arch Med Res 43 2012 305 311
11. C. Göǧüş, S. Baltaci, E. Filiz, A. Elhan, and Y. Bedük Significance of thrombocytosis for determining prognosis in patients with localized renal cell carcinoma Urology 63 2004 447 450
12. F. Erdemir, M. Kilciler, S. Bedir, Y. Ozgok, H. Coban, and K. Erten Clinical significance of platelet count in patients with renal cell carcinoma Urol Int 79 2007 111 116
13. S.G. Hwang, K.M. Kim, J.H. Cheong, H.I. Kim, J.Y. An, and W.J. Hyung et al. Impact of pretreatment thrombocytosis on blood-borne metastasis and prognosis of gastric cancer Eur J Surg Oncol 38 2012 562 567
14. K.M. Brown, C. Domin, G.V. Aranha, S. Yong, and M. Shoup Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas Am J Surg 189 2005 278 282
15. M.a. Brockmann, A. Giese, K. Mueller, F.J. Kaba, F. Lohr, and C. Weiss et al. Preoperative thrombocytosis predicts poor survival in patients with glioblastoma Neurooncol 9 2007 335 342
16. S. Taucher, A. Salat, M. Gnant, W. Kwasny, B. Mlineritsch, and R. Menzel et al. Impact of pretreatment thrombocytosis on survival in primary breast cancer Thromb Haemost 89 2003 1098 1106
17. G.J. Gasic, T.B. Gasic, and C.C. Stewart Antimetastatic effects associated with platelet reduction Proc Natl Acad Sci U S A 61 1968 46 52
18. E. Camerer, A.a. Qazi, D.N. Duong, I. Cornelissen, R. Advincula, and S.R. Coughlin Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis Blood 104 2004 397 401
19. S. Sevitt The structure and growth of valve-pocket thrombi in femoral veins J Clin Pathol 27 1974 517 528
20. J.F. Timp, S.K. Braekkan, H.H. Versteeg, and S.C. Cannegieter Epidemiology of cancer-associated venous thrombosis Blood 122 2013 1712 1723
21. F. Horsted, J. West, and M.J. Grainge Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis PLoS Med 9 2012 e1001275
22. S. Bouillaud, and J. Bouillard De l'Obliteration des veines et de son influence sur la formation des hydropisies partielles: consideration sur la hydropisies passive et general Arch Gen Med 1 1823 188 204
23. R. Simanek, R. Vormittag, C. Ay, G. Alguel, D. Dunkler, and I. Schwarzinger et al. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS) J Thromb Haemost 8 2010 114 120
24. A.A. Khorana, N.M. Kuderer, E. Culakova, G.H. Lyman, and C.W. Francis Development and validation of a predictive model for chemotherapy-associated thrombosis Blood 111 2008 4902 4907
25. J.G. White Platelet structure A.D. Michelson, Platelets 3rd ed 2012 Elsevier London 117 144
26. K. Kaushansky Lineage-specific hematopoietic growth factors N Engl J Med 354 2006 2034 2045
27. K. Kaushansky Thrombopoietin N Engl J Med 339 1998 746 754
28. K.J. Clemetson, and J.M. Clemetson Platelet Receptors A.D. Michelson, Platelets 3rd ed 2012 Elsevier London 169 193
29. M. Chechlinska, M. Kowalewska, and R. Nowak Systemic inflammation as a confounding factor in cancer biomarker discovery and validation Nat Rev Cancer 10 2010 2 3
30. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill Cancer-related inflammation Nature 454 2008 436 444
31. Y. Sasaki, T. Takahashi, H. Miyazaki, a. Matsumoto, T. Kato, and K. Nakamura et al. Production of thrombopoietin by human carcinomas and its novel isoforms Blood 94 1999 1952 1960
32. T. Ryu, S. Nishimura, H. Miura, H. Yamada, H. Morita, and H. Miyazaki et al. Thrombopoietin-producing hepatocellular carcinoma Intern Med 42 2003 730 734
33. M. Kowanetz, X. Wu, J. Lee, M. Tan, T. Hagenbeek, and X. Qu et al. Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes Proc Natl Acad Sci U S A 107 2010 21248 21255
34. J.S. Palumbo, K.E. Talmage, J.V. Massari, C.M. La Jeunesse, M.J. Flick, and K.W. Kombrinck et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells Blood 105 2005 178 185
35. L.J. Gay, and B. Felding-Habermann Contribution of platelets to tumour metastasis Nat Rev Cancer 11 2011 123 134
36. C. Medina, P. Jurasz, M.J. Santos-Martinez, S.S. Jeong, T. Mitsky, and R. Chen et al. Platelet aggregation-induced by caco-2 cells: regulation by matrix metalloproteinase-2 and adenosine diphosphate J Pharmacol Exp Ther 317 2006 739 745
37. E. Heinmöller, R.J. Weinel, H.H. Heidtmann, U. Salge, R. Seitz, and I. Schmitz et al. Studies on tumor-cell-induced platelet aggregation in human lung cancer cell lines J Cancer Res Clin Oncol 122 1996 735 744
38. J. Abecassis, A. Beretz, R. Millon-Collard, J.P. Fricker, M. Eber, and J.P. Cazenave In vitro interactions between human breast cancer cells MCF-7 and human blood platelets Thromb Res 47 1987 693 698
39. A. Mitrugno, D. Williams, S.W. Kerrigan, and N. Moran A novel and essential role for FcγRIIa in cancer cell-induced platelet activation Blood 123 2014 249 260
40. E. Heinmöller, T. Schropp, O. Kisker, B. Simon, R. Seitz, and R.J. Weinel Tumor cell-induced platelet aggregation in vitro by human pancreatic cancer cell lines Scand J Gastroenterol 30 1995 1008 1016
41. P. Jurasz, G. Sawicki, M. Duszyk, J. Sawicka, C. Miranda, and I. Mayers et al. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide Cancer Res 61 2001 376 382
42. K.V. Honn, P. Cavanaugh, C. Evens, J.D. Taylor, and B.F. Sloane Tumor cell-platelet aggregation: induced by cathepsin B-like proteinase and inhibited by prostacyclin Science 217 1982 540 542
43. Y.W. Van den Berg, S. Osanto, P.H. Reitsma, and H.H. Versteeg The relationship between tissue factor and cancer progression: insights from bench and bedside Blood 119 2012 924 932
44. E. Van der Pol, A.N. Böing, P. Harrison, A. Sturk, and R. Nieuwland Classification, functions, and clinical relevance of extracellular vesicles Pharmacol Rev 64 2012 676 705
45. J.E. Geddings, and N. Mackman Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients Blood 122 2013 1873 1880
46. M.E.T. Tesselaar, FPHTM Romijn, I.K. Van Der Linden, F.a. Prins, R.M. Bertina, and S. Osanto Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 5 2007 520 527
47. J.I. Zwicker, H.A. Liebman, D. Neuberg, R. Lacroix, K.a. Bauer, and B.C. Furie et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy Clin Cancer Res 15 2009 6830 6840
48. G.M. Thomas, L. Panicot-Dubois, R. Lacroix, F. Dignat-George, D. Lombardo, and C. Dubois Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo J Exp Med 206 2009 1913 1927
49. M. Demers, and D.D. Wagner NETosis: A new factor in tumor progression and cancer-associated thrombosis Semin Thromb Hemost 2014
50. V. Brinkmann, U. Reichard, C. Goosmann, B. Fauler, Y. Uhlemann, and D.S. Weiss et al. Neutrophil extracellular traps kill bacteria Science 303 2004 1532 1535
51. M. Demers, D.S. Krause, D. Schatzberg, K. Martinod, J.R. Voorhees, and T.A. Fuchs et al. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis Proc Natl Acad Sci U S A 109 2012 13076 13081
52. T.A. Fuchs, A. Brill, D. Duerschmied, D. Schatzberg, M. Monestier, and D.D. Myers et al. Extracellular DNA traps promote thrombosis Proc Natl Acad Sci U S A 107 2010 15880 15885
53. J. Riedl, I. Pabinger, and C. Ay Platelets in cancer and thrombosis Hamostaseologie 34 2014 54 62
54. C. Ay, R. Simanek, R. Vormittag, D. Dunkler, G. Alguel, and S. Koder et al. High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS) Blood 112 2008 2703 2708
55. M. Di Nisio, N. Ferrante, B. Feragalli, M. De Tursi, S. Iacobelli, and F. Cuccurullo et al. Arterial thrombosis in ambulatory cancer patients treated with chemotherapy Thromb Res 127 2011 382 383
56. G. Numico, O. Garrone, V. Dongiovanni, N. Silvestris, I. Colantonio, and G. Di Costanzo et al. Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine Cancer 103 2005 994 999
57. F.a.B. Schutz, Y. Je, G.R. Azzi, P.L. Nguyen, and T.K. Choueiri Bevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomes Ann Oncol 22 2011 1404 1412
58. P.M. Rothwell, F.G.R. Fowkes, J.F.F. Belch, H. Ogawa, C.P. Warlow, and T.W. Meade Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials Lancet 377 2011 31 41
59. P.M. Rothwell, M. Wilson, J.F. Price, J.F.F. Belch, T.W. Meade, and Z. Mehta Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials Lancet 379 2012 1591 1601
60. M.S. Reimers, E. Bastiaannet, R.E. Langley, R. van Eijk, R.L.P. van Vlierberghe, and V.E.P. Lemmens et al. Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer JAMA Intern Med 2014 1 8
61. C.R. Cardwell, A.T. Kunzmann, M.M. Cantwell, C. Hughes, J.A. Baron, and D.G. Powe et al. Low-dose aspirin use after diagnosis of colorectal cancer does not increase survival: a case-control analysis of a population-based cohort Gastroenterology 146 2014 700 708 (e2)
62. J. Cuzick, F. Otto, J.a. Baron, P.H. Brown, J. Burn, and P. Greenwald et al. Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement Lancet Oncol 10 2009 501 507
63. E.A. Akl, S. Gunukula, M. Barba, V.E.D. Yosuico, F.F. van Doormaal, and S. Kuipers et al. Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Cochrane Database Syst Rev 2011 CD006652
64. F.F. Van Doormaal, M. Di Nisio, H.M. Otten, D.J. Richel, M. Prins, and H.R. Buller Randomized trial of the effect of the low molecular weight heparin nadroparin on survival in patients with cancer J Clin Oncol 29 2011 2071 2076
65. G.H. Lyman, A.a. Khorana, N.M. Kuderer, A.Y. Lee, J.I. Arcelus, and E.P. Balaban et al. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update J Clin Oncol 31 2013